Drug Type siRNA |
Synonyms |
Target |
Action antagonists, inhibitors |
Mechanism SULF2 antagonists(sulfatase 2 antagonists), TGF-β1 inhibitors(Transforming growth factor beta 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Preclinical | United States | - | |
Lung Cancer | Preclinical | United States | - | |
Pancreatic Cancer | Preclinical | United States | - |